cjc-1295 ipamorelin gh release mechanism growth hormone secretagogue is one of the several non-FDA approved releasing CJC-1295/Ipamorelin for Women: GH Therapy

It was originally developed to treat growth hormone deficiencies but has become popular in the worlds of anti-aging, bodybuilding, and recovery enhancement due to its extended half-life and stable release profile

Not for Human or Animal Use

Who participates in First-in-Human trials, and how are participants informed and protected

The claim that ipamorelin is more selective than older GH secretagogues comes from early data showing it triggers less cortisol and prolactin release than alternatives

People with active psychosis, hypertension, uncontrolled heart problems, or a history of substance misuse are usually not good candidates